Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic

被引:137
作者
Oskowitz, Adam [1 ]
McFerrin, Harris [1 ]
Gutschow, Miriam [1 ]
Carter, Mary Leita [1 ]
Pochampally, Radhika [1 ,2 ,3 ]
机构
[1] Tulane Univ, Hlth Sci Ctr, Ctr Gene Therapy, New Orleans, LA 70118 USA
[2] Tulane Univ, Hlth Sci Ctr, Dept Pharmacol, New Orleans, LA 70118 USA
[3] Tulane Univ, Hlth Sci Ctr, Tulane Canc Ctr, New Orleans, LA 70118 USA
关键词
STEM-CELLS; ENDOTHELIAL-CELLS; BONE-MARROW; GROWTH-FACTOR; INFARCTED MYOCARDIUM; PROGENITOR CELLS; REPAIR; TRANSDIFFERENTIATION; NEOVASCULARIZATION; DIFFERENTIATION;
D O I
10.1016/j.scr.2011.01.004
中图分类号
Q813 [细胞工程];
学科分类号
100113 [医学细胞生物学];
摘要
Recent reports have indicated that mesenchymal stromal cells (MSCs) from bone marrow have a potential in vascular remodeling and angiogenesis. Here, we report a unique phenomenon that under serum-deprived conditions MSCs survive and replicate. Secretome analysis of MSCs grown under serum-deprived conditions (SD-MSCs) identified a significant upregulation of prosurvival and angiogenic factors including VEGF-A, ANGPTs, IGF-1, and HGF. An ex vivo rat aortic assay demonstrated longer neovascular sprouts generated from rat aortic rings cultured in SD-MSC-conditioned media compared to neovascular sprouts from aortas grown in MSC-conditioned media. With prolonged serum deprivation, a subpopulation of SD-MSCs began to exhibit an endothelial phenotype. This population expressed endothelial-specific proteins including VEGFR2, Tie2/TEK, PECAM/CD31, and eNOS and also demonstrated the ability to uptake acetylated LDL. SD-MSCs also exhibited enhanced microtubule formation in an in vitro angiogenesis assay. Modified chick chorioallantoic membrane (CAM) angiogenesis assays showed significantly higher angiogenic potential for SD-MSCs compared to MSCs. Analysis of CAMs grown with SD-MSCs identified human-specific CD31-positive cells in vascular structures. We conclude that under the stress of serum deprivation MSCs are highly angiogenic and a population of these cells has the potential to differentiate into endothelial-like cells. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:215 / 225
页数:11
相关论文
共 32 条
[1]
Therapeutic angiogenesis using autologous bone marrow stromal cells: Improved blood flow in a chronic limb ischemia model [J].
Al-Khaldi, A ;
Al-Sabti, H ;
Galipeau, J ;
Lachapelle, K .
ANNALS OF THORACIC SURGERY, 2003, 75 (01) :204-209
[2]
Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets [J].
Aoki, M ;
Morishita, R ;
Taniyama, Y ;
Kida, I ;
Moriguchi, A ;
Matsumoto, K ;
Nakamura, T ;
Kaneda, Y ;
Higaki, J ;
Ogihara, T .
GENE THERAPY, 2000, 7 (05) :417-427
[3]
Isolation of putative progenitor endothelial cells for angiogenesis [J].
Asahara, T ;
Murohara, T ;
Sullivan, A ;
Silver, M ;
vanderZee, R ;
Li, T ;
Witzenbichler, B ;
Schatteman, G ;
Isner, JM .
SCIENCE, 1997, 275 (5302) :964-967
[4]
Angiogenesis assays: A critical overview [J].
Auerbach, R ;
Lewis, R ;
Shinners, B ;
Kubai, L ;
Akhtar, N .
CLINICAL CHEMISTRY, 2003, 49 (01) :32-40
[5]
Stem cells in tissue engineering [J].
Bianco, P ;
Robey, PG .
NATURE, 2001, 414 (6859) :118-121
[6]
Treatment of neural injury with marrow stromal cells [J].
Chopp, M ;
Li, Y .
LANCET NEUROLOGY, 2002, 1 (02) :92-100
[7]
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement [J].
Dominici, M. ;
Le Blanc, K. ;
Mueller, I. ;
Slaper-Cortenbach, I. ;
Marini, F. C. ;
Krause, D. S. ;
Deans, R. J. ;
Keating, A. ;
Prockop, D. J. ;
Horwitz, E. M. .
CYTOTHERAPY, 2006, 8 (04) :315-317
[8]
Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells [J].
Gnecchi, M ;
He, HM ;
Liang, OD ;
Melo, LG ;
Morello, F ;
Mu, H ;
Noiseux, N ;
Zhang, LN ;
Pratt, RE ;
Ingwall, JS ;
Dzau, VJ .
NATURE MEDICINE, 2005, 11 (04) :367-368
[9]
Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis [J].
Hung, Shih-Chieh ;
Pochampally, Radhika R. ;
Chen, Sy-Chi ;
Hsu, Shu-Ching ;
Prockop, Darwin J. .
STEM CELLS, 2007, 25 (09) :2363-2370
[10]
Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia [J].
Iwase, T ;
Nagaya, N ;
Fujii, T ;
Itoh, T ;
Murakami, S ;
Matsumoto, T ;
Kangawa, K ;
Kitamura, S .
CARDIOVASCULAR RESEARCH, 2005, 66 (03) :543-551